Status:
UNKNOWN
The Inflammatory Burden in Hemodialysis vs. Peritoneal Dialysis Patients: the Role of Alpha-defensin
Lead Sponsor:
Hillel Yaffe Medical Center
Conditions:
Kidney Failure
Inflammation
Eligibility:
All Genders
18-80 years
Phase:
NA
Brief Summary
The aim of this study is to determine the levels of alpha-defensin throughout the hemodialysis course compared to the levels at the end of a course of peritoneal dialysis, as a reflection of the infla...
Eligibility Criteria
Inclusion
- Kidney failure patients undergoing hemodialysis or peritoneal dialysis
Exclusion
- Active inflammatory or infectious disease
Key Trial Info
Start Date :
March 1 2019
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
March 1 2020
Estimated Enrollment :
80 Patients enrolled
Trial Details
Trial ID
NCT03845530
Start Date
March 1 2019
End Date
March 1 2020
Last Update
February 19 2019
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Hillel Yaffe Medical Center
Hadera, Israel, 38100